300584 海辰药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)3.1634.0013.7483.41435.075
总资产报酬率 ROA (%)2.2172.7992.6872.50025.889
投入资产回报率 ROIC (%)2.4183.0272.9042.67427.395

边际利润分析
销售毛利率 (%)83.37983.15181.34675.30481.150
营业利润率 (%)6.7608.2897.5885.71857.287
息税前利润/营业总收入 (%)8.4279.9388.6996.66558.321
净利润/营业总收入 (%)6.8287.9637.0136.10249.252

收益指标分析
经营活动净收益/利润总额(%)133.805121.168112.609125.6437.510
价值变动净收益/利润总额(%)-7.9310.0080.1063.22992.697
营业外收支净额/利润总额(%)8.537-1.896-4.254-4.605-0.258

偿债能力分析
流动比率 (X)1.0081.0650.9431.1931.002
速动比率 (X)0.7900.8100.7390.9910.819
资产负债率 (%)27.64929.11329.90826.53727.153
带息债务/全部投入资本 (%)21.62922.98322.70818.33718.550
股东权益/带息债务 (%)357.121329.079333.256433.349416.264
股东权益/负债合计 (%)254.385239.916234.355276.827268.811
利息保障倍数 (X)8.1355.5136.1225.55849.384

营运能力分析
应收账款周转天数 (天)98.678138.243136.316101.31661.430
存货周转天数 (天)278.829353.993271.296165.152209.273